GlassScriptPhysician profile
Orville H Dyce
NPI 1245260470
$6,183.15
in general payments reported to CMS, 2019-2025
38 companies · $1,527 in 2025
The $1,527 reported for 2025 was more than what 86% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,155 · 2020: $381 · 2021: $753 · 2022: $836 · 2023: $808 · 2024: $723 · 2025: $1,527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,665 · Education: $223 · Travel and Lodging: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,665.28 |
| Education | $222.96 |
| Travel and Lodging | $169.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,045.63 | 2019-2025 | Airsupra, Breztri, Fasenra |
| Genzyme Corporation | $932.52 | 2019-2025 | |
| Optinose US, INC. | $512.78 | 2019-2025 | |
| Jazz Pharmaceuticals INC. | $491.02 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $394.98 | 2019-2025 | |
| Merz North America, INC. | $384.79 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $370.12 | 2023-2025 | Dupixent |
| Stryker Corporation | $319.52 | 2019-2021 | |
| Glaxosmithkline, LLC. | $304.31 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Axsome Therapeutics, INC. | $191.43 | 2022-2025 | Sunosi |
| Microaire Surgical Instruments LLC | $169.86 | 2025 | |
| Amgen INC. | $133.95 | 2022-2025 | Tezspire |
| Itamar Medical INC | $105.43 | 2025 | Watchpatone |
| Abbvie INC. | $94.94 | 2023-2025 | Botox |
| Integra Lifesciences Corporation | $90.79 | 2024-2025 | Inspira Air, Acclarent Aera, Trudi Probe |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $67.52 | 2020-2021 | |
| Medtronic, INC. | $46.91 | 2022-2023 | Ligasure |
| Avadel Cns Pharmaceuticals, LLC | $46.12 | 2024 | Lumryz |
| Genentech USA, INC. | $41.44 | 2019-2022 | |
| Resmed Corp | $37.42 | 2019-2024 | |
| Alk-Abello, INC | $35.01 | 2020-2021 | |
| Acclarent, INC | $33.67 | 2023 | Trudi Nav Cable, Relieva Spinplus |
| Kaleo, INC. | $31.79 | 2022 | |
| Smith+Nephew, INC. | $30.40 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $29.68 | 2024-2025 | Voquezna |
| Merck Sharp & Dohme LLC | $28.22 | 2019-2023 | |
| Revance Therapeutics, INC. | $24.10 | 2025 | Daxxify |
| Allergan, INC. | $24.03 | 2019 | |
| Aerin Medical INC. | $23.43 | 2024 | |
| Ars Pharmaceuticals Operations, INC. | $22.21 | 2025 | Neffy |
| Fortovia Therapeutics, INC. | $19.60 | 2020 | |
| Aimmune Therapeutics, INC. | $17.06 | 2022 | |
| Sanofi-Aventis U.S. LLC | $16.19 | 2020 | |
| Lilly USA, LLC | $15.53 | 2025 | Zepbound |
| Idorsia Pharmaceuticals US INC | $13.22 | 2023 | Quviviq |
| Hikma Pharmaceuticals USA | $12.93 | 2022 | |
| Horizon Therapeutics Plc | $12.45 | 2020 | |
| Galderma Laboratories, L.P. | $12.15 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Orville Dyce listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.